| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Department of Radiology, Stanford University School of Medicine, San Francisco, Calif.)
Intact and castrate male C57 black mice were irradiated and injected twice weekly for 10 weeks with an aqueous testosterone suspension; the corresponding litter-mate control groups were also irradiated and injected with a placebo of the suspension medium alone. Net lymphoid tumor incidence by groups was: (a) intact + x-ray + placebo, 39 of 52 mice (75 per cent); (b) castrate + x-ray + placebo, 45 of 52 mice (87 per cent); (c) intact + x-ray + testosterone, 4 of 49 mice (8 per cent); and (d) castrate + x-ray + testosterone, 5 of 50 mice (10 per cent). Some possible mechanisms for this pronounced inhibition are briefly discussed.
* This investigation was supported by a grant from the National Cancer Institute, Public Health Service.
Received 4/28/51.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |